Supakarn Chamni

1.1k total citations
56 papers, 726 citations indexed

About

Supakarn Chamni is a scholar working on Cancer Research, Pharmacology and Biotechnology. According to data from OpenAlex, Supakarn Chamni has authored 56 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cancer Research, 20 papers in Pharmacology and 18 papers in Biotechnology. Recurrent topics in Supakarn Chamni's work include Synthesis and Biological Activity (21 papers), Marine Sponges and Natural Products (17 papers) and Microbial Natural Products and Biosynthesis (15 papers). Supakarn Chamni is often cited by papers focused on Synthesis and Biological Activity (21 papers), Marine Sponges and Natural Products (17 papers) and Microbial Natural Products and Biosynthesis (15 papers). Supakarn Chamni collaborates with scholars based in Thailand, Japan and China. Supakarn Chamni's co-authors include Pithi Chanvorachote, Khanit Suwanborirux, Naoki Saito, Thanyada Rungrotmongkol, Wanchai De‐Eknamkul, Panupong Mahalapbutr, Chatchai Chaotham, Prasit Pavasant, Daniel Romo and Piyamas Sumrejkanchanakij and has published in prestigious journals such as Chemical Communications, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Supakarn Chamni

50 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Supakarn Chamni Thailand 18 270 210 200 164 157 56 726
Shian‐Ren Lin Taiwan 16 399 1.5× 110 0.5× 143 0.7× 54 0.3× 125 0.8× 25 915
Claire M. Pfeffer United States 5 755 2.8× 176 0.8× 110 0.6× 175 1.1× 68 0.4× 5 1.3k
Marie-Hélène Teiten Luxembourg 14 426 1.6× 59 0.3× 129 0.6× 116 0.7× 63 0.4× 15 859
Dilip M. Mondhe India 20 535 2.0× 69 0.3× 148 0.7× 185 1.1× 43 0.3× 30 1.1k
Changqi Zhao China 20 636 2.4× 78 0.4× 240 1.2× 128 0.8× 44 0.3× 47 1.1k
Dilip M. Mondhe India 20 532 2.0× 82 0.4× 180 0.9× 343 2.1× 24 0.2× 43 1.1k
Taichi Ohshiro Japan 20 548 2.0× 107 0.5× 266 1.3× 138 0.8× 112 0.7× 72 1.1k
Keguang Cheng China 18 805 3.0× 66 0.3× 103 0.5× 328 2.0× 40 0.3× 58 1.2k
Kuan‐Han Lee Taiwan 19 292 1.1× 43 0.2× 232 1.2× 211 1.3× 68 0.4× 36 817

Countries citing papers authored by Supakarn Chamni

Since Specialization
Citations

This map shows the geographic impact of Supakarn Chamni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Supakarn Chamni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Supakarn Chamni more than expected).

Fields of papers citing papers by Supakarn Chamni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Supakarn Chamni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Supakarn Chamni. The network helps show where Supakarn Chamni may publish in the future.

Co-authorship network of co-authors of Supakarn Chamni

This figure shows the co-authorship network connecting the top 25 collaborators of Supakarn Chamni. A scholar is included among the top collaborators of Supakarn Chamni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Supakarn Chamni. Supakarn Chamni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jansook, Phatsawee, Supakarn Chamni, Rathapon Asasutjarit, et al.. (2025). Development of piperine/HPβCD-loaded PVA-coated iron oxide nanoparticles in in situ gel for enhanced retinal delivery and anti-VEGF activity. European Journal of Pharmaceutics and Biopharmaceutics. 218. 114931–114931.
2.
3.
Chou, Chao‐Kai, et al.. (2025). Microbiome profiling and Actinomycetes isolation from tropical marine sponges. AIMS Microbiology. 11(1). 182–205.
4.
Leelahavanichkul, Asada, et al.. (2024). Inulin supplementation exhibits increased muscle mass via gut-muscle axis in children with obesity: double evidence from clinical and in vitro studies. Scientific Reports. 14(1). 11181–11181. 9 indexed citations
5.
Wangkanont, Kittikhun, Kowit Hengphasatporn, Ryuhei Harada, et al.. (2024). Alpha and gamma mangostins inhibit wild-type B SARS-CoV-2 more effectively than the SARS-CoV-2 variants and the major target is unlikely the 3C-like protease. Heliyon. 10(11). e31987–e31987. 1 indexed citations
6.
Maiuthed, Arnatchai, Wongsakorn Phongsopitanun, Roonglawan Rattanajak, et al.. (2023). N-Containing α-Mangostin Analogs via Smiles Rearrangement as the Promising Cytotoxic, Antitrypanosomal, and SARS-CoV-2 Main Protease Inhibitory Agents. Molecules. 28(3). 1104–1104. 5 indexed citations
7.
Sanachai, Kamonpan, Panupong Mahalapbutr, Lueacha Tabtimmai, et al.. (2023). In Silico and In Vitro Study of Janus Kinases Inhibitors from Naphthoquinones. Molecules. 28(2). 597–597. 3 indexed citations
8.
9.
10.
Chanvorachote, Pithi, Chaisak Chansriniyom, Khanit Suwanborirux, et al.. (2023). Semisynthesis of 5-O-ester derivatives of renieramycin T and their cytotoxicity against non-small-cell lung cancer cell lines. Scientific Reports. 13(1). 21485–21485.
11.
Junthip, Jatupol, Supakarn Chamni, Chaisak Chansriniyom, et al.. (2023). A promising synthetic citric crosslinked β-cyclodextrin derivative for antifungal drugs: Solubilization, cytotoxicity, and antifungal activity. International Journal of Pharmaceutics. 645. 123394–123394. 6 indexed citations
12.
Chamni, Supakarn, et al.. (2022). Effects of inulin supplementation on body composition and metabolic outcomes in children with obesity. Scientific Reports. 12(1). 13014–13014. 25 indexed citations
13.
14.
Suwanborirux, Khanit, et al.. (2021). 22-O-(N-Boc-l-glycine) ester of renieramycin M inhibits migratory activity and suppresses epithelial–mesenchymal transition in human lung cancer cells. Journal of Natural Medicines. 75(4). 949–966. 7 indexed citations
15.
Wichadakul, Duangdao, et al.. (2021). Hydroquinone 5-O-Cinnamoyl Ester of Renieramycin M Suppresses Lung Cancer Stem Cells by Targeting Akt and Destabilizes c-Myc. Pharmaceuticals. 14(11). 1112–1112. 16 indexed citations
16.
Chamni, Supakarn, et al.. (2020). The investigation of binary and ternary sulfobutylether-β-cyclodextrin inclusion complexes with asiaticoside in solution and in solid state. Carbohydrate Research. 498. 108190–108190. 37 indexed citations
17.
Chamni, Supakarn, et al.. (2019). Jorunnamycin A from Xestospongia sp. Suppresses Epithelial to Mesenchymal Transition and Sensitizes Anoikis in Human Lung Cancer Cells. Journal of Natural Products. 82(7). 1861–1873. 22 indexed citations
18.
Wright, Megan H., et al.. (2017). Quantitative chemoproteomic profiling reveals multiple target interactions of spongiolactone derivatives in leukemia cells. Chemical Communications. 53(95). 12818–12821. 10 indexed citations
19.
Maiuthed, Arnatchai, et al.. (2017). Apoptosis-inducing Effect of Hydroquinone 5-O-Cinnamoyl Ester Analog of Renieramycin M on Non-small Cell Lung Cancer Cells. Anticancer Research. 37(11). 6259–6267. 11 indexed citations
20.
Chanvorachote, Pithi, et al.. (2016). Potential Anti-metastasis Natural Compounds for Lung Cancer. Anticancer Research. 36(11). 5707–5718. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shian‐Ren Lin Breakdown of academic impact, for papers by Claire M. Pfeffer Breakdown of academic impact, for papers by Marie-Hélène Teiten Breakdown of academic impact, for papers by Dilip M. Mondhe Breakdown of academic impact, for papers by Changqi Zhao Breakdown of academic impact, for papers by Dilip M. Mondhe Breakdown of academic impact, for papers by Taichi Ohshiro Breakdown of academic impact, for papers by Keguang Cheng Breakdown of academic impact, for papers by Kuan‐Han Lee
Rankless by CCL
2026